Search
Search Constraints
You searched for: Is Part Of Cancer letters. Volume 387(2017)Limit your search
- 616.994 16
- Cancer -- Periodicals 16
- Cancer -- Périodiques 16
- Electronic journals 16
- Neoplasms -- Periodicals 16
- ABCB1 ATP-binding cassette, Sub-family B, Member 1 -- ABCG2 ATP-binding cassette, Sub-family G, Member 2 -- AKT V-Akt murine thymoma viral oncogene -- APC adenomatous polyposis coli -- AQ4N di-N-oxide aliphatic amino anthracenedione -- BRAF b-Raf proto-oncogene -- BRCA breast cancer gene -- CDK2N cyclin-dependent kinase 2 -- CSCs cancer stem cells -- EGFR epidermal growth factor receptor -- EMT epithelial to mesenchymal transition -- ER estrogen receptors -- FBXW7 f-box and WD repeat domain containing 7 -- HCC hepatocellular carcinoma -- HDAC histone deacetylase -- HIF hypoxia inducible factor -- KRAS the human homolog of the Kirsten rat sarcoma-2 virus oncogene -- MAPK mitogen-activated protein kinase -- MEK mitogen-activated protein kinase -- MMPs matrix metalloproteinase -- NF nuclear factor -- NRAS neuroblastome RAS viral oncogene: -- NSCLC non-small cell lung carcinoma -- PIK3CA phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha -- PTEN phosphatase and tensin homolog -- siRNA small interfering RNA -- SAHA suberoylanilide hydroxamic acid -- SMAD4 SMAD family member 4 -- SP side population -- TERT telomerase reverse transcriptase -- TGF-β1 transforming growth factor, beta 1 -- TIMP-2 tissue inhibitor of matrix metalloproteinase-2 -- TMZ Temozolomide -- TP53 tumor protein 53 -- ZEB1 zinc finger E-box binding homebox 1 1
- AIM2 absent in melanoma 2 -- ALRs AIM2-like receptors -- AMPK AMP-activated protein kinase -- ASC apoptosis-associated speck-like protein containing CARD -- ASK apoptotic signal-regulating kinase -- ATF activating transcription factor -- BCR B cell receptor -- CAC colitis-associated cancer -- CARD9/Bcl-10/Malt1 caspase recruitment domain family member 9/B cell leukemia/lymphoma 10/mucosa associated lymphoid tissue lymphoma translocation gene 1 -- CDK cyclin-dependent kinase -- cIAPs cellular inhibitor of apoptosis proteins -- CLRs C-type lectin receptors -- CREB cAMP response element binding protein -- CTL cytotoxic lymphocyte -- DAI DNA-dependent activator of interferon-regulatory factors -- DAMP danger-associated molecular patterns -- DCBLD2 discoidin, CUB and LCCL domain containing 2 -- DDX41 DEAD-box helicase 41 -- DLK delta like non-canonical Notch ligand -- DNA-PK DNA-dependent protein kinase -- DSS/AOM azoxymethane/dextran sulfate sodium -- DUOX dual oxidase -- EGFR endothelial growth factor receptor -- ER endoplasmic reticulum -- ERBIN Erbb2 interacting protein -- ERK extracellular signal-regulated kinase -- FADD FAS-associated protein with death domain -- FOXO1 forkhead box protein O1 -- FRMPD FERM and PDZ domain-containing protein -- G6PD glucose-6-phosphate dehydrogenase -- HCC hepatocellular carcinoma -- HDAC histone deacetylase -- HFD high-fat diet -- HMGB high-mobility group box -- iE-DAP γ-d-Glu-mDAP -- IFN interferon -- IKK IκB kinase -- IL interleukin -- IPS interferon-β promoter-stimulator -- IRAK IL-1 receptor-associated kinase -- IRF IFN regulatory factor -- ISGF interferon-stimulated gene factor -- JNK c-Jun N-terminal kinase -- KRAS Kirsten rat sarcoma viral oncogene -- LGP laboratory of genetics and physiology -- LRR leucine-rich repeat -- LUBAC linear ubiquitin complex -- Mal MyD88 adaptor-like -- MAP3K mitogen-activated protein kinase kinase kinase -- MAPK mitogen-activated protein kinase -- MAVS mitochondrial antiviral signaling protein -- MCD methionine choline deficient -- MDA melanoma differentiation-associated factor gene -- DC dendritic cell -- MEK MAPK/ERK kinase -- MHC major histocompatibility complex -- MRE11 double-strand break repair protein MRE11 -- mTORC1 mammalian target of rapamycin complex -- MyD88 myeloid differentiation factor 88 -- NACHT NAIP (neuronal apoptosis inhibitor protein), CIITA (MHC class 2 transcription activator), HET-E (incompatibility locus protein from Podospora anserina) and TP1 (telomerase-associated protein) -- NADPH nicotinamide adenine dinucleotide phosphate -- NAIP neuronal apoptosis inhibitor protein -- NALP NLR family, pyrin domain containing -- NBD nucleotide-binding domain -- NEMO nuclear factor (NF)-κB essential modulator -- NIH NF-κB-inducing kinase -- NOD nucleotide-binding oligomerization domain -- NOS nitric oxide synthase -- NLRA acidic-containing NLR -- NLRC CARD-containing NLR -- NLRP PYRIN-containing NLR -- NLRs NOD-like receptors -- NLRX1 NLR family member X1 -- PAMP pathogen-associated molecular patterns -- PD-1 programmed death 1 -- PPARγ peroxisome proliferator-activated receptor gamma -- PRR pattern-recognition receptors -- RalB v-ral simian leukemia viral oncogene homolog B -- RIG-I retinoic acid-inducible gene I -- RIP2 receptor-interacting protein 2 -- RLRs RIG-I-like receptors -- STAT1 signal transducer and activator of transcription 1 -- STING stimulator of interferon genes PYHIN -- SOD1 superoxide dismutase 1 -- Syk spleen tyrosine kinase -- TAB2 TGF-β-activated kinase 1/MAP3K7-binding protein 2 -- TAK1 TGF-β-activated kinase 1 -- TANK TRAF family member-associated NF-κB activator -- TBK TRAF family member-associated NF-κB activator-binding kinase -- T2DM type 2 diabetes mellitus -- TGF transforming growth factor -- TIR Toll/IL-1 receptor -- TIRAP TIR domain-containing adaptor protein -- TLRs Toll-like receptors -- TNF tumor necrosis factor -- TRADD TNFR-associated death domain -- TRAF TNF receptor-associated factor -- TRAM TRIF-related adaptor molecule -- VSMC vascular smooth muscle cells -- xIAP X-linked inhibitor of apoptosis protein -- Y750 tyrosine 750 1
- AML acute myeloid leukemia -- ATRA all-trans retinoic acid -- bFGF basic fibroblast growth factor -- CAFs cancer-associated fibroblasts -- CAM-DR cell adhesion-mediated drug resistance -- CCL2 chemokine (C-C motif) ligand 2 -- CLL chronic lymphocytic leukemia -- CSF1 colony-stimulating factor 1 -- CXCL1/2 chemokine (C-X-C motif) ligand 1/2 -- CXCR4 chemokine (C-X-C motif) receptor 4 -- ECM extracellular matrix -- EM-DR environment-mediated drug resistance -- ERK1/2 extracellular signal-regulated kinase 1/2 -- FGF fibroblast growth factor -- FGFR3 fibroblast growth factor receptor 3 -- GM-CSF granulocyte-macrophage colony-stimulating factor -- HGF hepatocyte growth factor -- IFNγ interferon γ -- IGF1 insulin-like growth factor 1 -- MAPK mitogen-activated protein kinase -- MDSCs myeloid-derived suppressor cells -- MM multiple myeloma -- MMPs matrix metalloproteinases -- PDGF platelet-derived growth factor -- PI3K phosphoinositol 3 kinase -- PKC protein kinase C -- SDF1 stromal cell-derived factor 1 -- SFM-DR soluble factor-mediated drug resistance -- TAMs tumor-associated macrophages -- TECs tumor-associated endothelial cells -- TNFα tumor necrosis factor α -- TGF transforming growth factor -- TKIs tyrosine kinase inhibitors -- TME tumor microenvironment -- VEGF vascular endothelial growth factor 1
- CAF cancer associated fibroblasts -- DEN diethylnitrosamine -- DPP dipeptidyl peptidase -- ECM extracellular matrix -- EGF epidermal growth factor -- EMT epithelial–mesenchymal transition -- FAP fibroblast activation protein -- FGF fibroblast growth factor -- HCC hepatocellular carcinoma -- HFD high fat diet -- HSC hepatic stellate cells -- MMP matrix metalloproteinase -- NMDA N-nitrosodiethylamine -- PB phenobarbital -- TAA thioacetamide -- TAM tumour associated macrophages 1
- CRISPR -- Cas9 -- Genome engineering -- Cancer -- Mouse models 1